C
Power Law company profile
Cellectis
Biotech & Life Sciences · Paris, France · Founded 1999 · IPO 2007 Unicorn
Valuation
$246M
Market cap · Apr/2026
Revenue
$73M
Latest reported FY
Global footprint
Where Cellectis has talent and traffic
AI talent share
0.4%
of workforce is AI talent
(1 of 237 staff)
(1 of 237 staff)
Core AI00%
Other AI10.42%
Non-AI workforce23699.58%
Web traffic by country
11K
monthly visits
across markets
across markets
🇺🇸 United States59.1%
🇫🇷 France16.4%
🇬🇧 United Kingdom8.2%
🇪🇸 Spain7.3%
🇧🇪 Belgium4.5%
Patent intelligence
$157M patent portfolio · 98 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$157M
64.0% of market cap · 5× smaller than top peer BioNTech ($780M)
98 active patent families
Where Cellectis innovates
Molecular biologyNucleaseMeganucleaseCell biologyImmunology
Above peer median on Legal, Market
Quality vs same-sector peers
Cellectis on the five Patsnap quality dimensions
Cellectis in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Cellectis concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Cellectis and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Cellectis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.